Biohaven Pharmaceutical Holding Company Ltd
NYSE:BHVN

Watchlist Manager
Biohaven Pharmaceutical Holding Company Ltd Logo
Biohaven Pharmaceutical Holding Company Ltd
NYSE:BHVN
Watchlist
Price: 13.11 USD -2.96% Market Closed
Market Cap: $1.7B

Profitability Summary

Biohaven Pharmaceutical Holding Company Ltd's profitability score is 15/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

15/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

15/100
Profitability
Score
15/100
Profitability
Score

Margins

Earnings Waterfall
Biohaven Pharmaceutical Holding Company Ltd

Margins Comparison
Biohaven Pharmaceutical Holding Company Ltd Competitors

Country Company Market Cap Operating
Margin
Net
Margin
US
Biohaven Pharmaceutical Holding Company Ltd
NYSE:BHVN
1.7B USD
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
389.3B USD
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
187.3B USD
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
170.5B USD
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
121.2B USD
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
80.1B USD
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
88.6B AUD
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
42.4B EUR
Loading...
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
47.4B USD
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Biohaven Pharmaceutical Holding Company Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Biohaven Pharmaceutical Holding Company Ltd
NYSE:BHVN
1.7B USD
Loading...
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
389.3B USD
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
187.3B USD
Loading...
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
170.5B USD
Loading...
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
121.2B USD
Loading...
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
80.1B USD
Loading...
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
88.6B AUD
Loading...
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
42.4B EUR
Loading...
Loading...
Loading...
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
47.4B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Biohaven Pharmaceutical Holding Company Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate